4//SEC Filing
McCulloch Kevin 4
Accession 0002031695-26-000002
CIK 0001867096other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 5:34 PM ET
Size
5.8 KB
Accession
0002031695-26-000002
Insider Transaction Report
Form 4
McCulloch Kevin
See Remarks
Transactions
- Sale
Common Stock
2026-01-08$8.00/sh−15,000$120,000→ 1,685,426 total
Holdings
- 25,000(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Xeris Biopharma Holdings, Inc.
CIK 0001867096
Entity typeother
Related Parties
1- filerCIK 0002031695
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 5:34 PM ET
- Size
- 5.8 KB